A patient with a humeral fracture is returning for a 4-week checkup. The nurse explains that initial evidence of healing on x-ray is indicated by

Choice A reason: Ankylosis, fusion of spinal joints, is associated with ankylosing spondylitis, not osteoporosis. Osteoporosis causes bone density loss, leading to fractures and deformities like kyphosis, not joint fusion. Expecting ankylosis misaligns assessment, potentially overlooking osteoporosis-related vertebral compression fractures critical for managing mobility and pain in older adults.

Choice B reason: Kyphosis, an exaggerated thoracic spine curvature, is common in osteoporosis due to vertebral compression fractures from weakened bones. These fractures collapse anteriorly, causing a hunchback appearance, affecting posture and balance. Recognizing kyphosis guides interventions like bracing or bisphosphonates to prevent further fractures and improve quality of life.

Choice C reason: Scoliosis, lateral spine curvature, is typically congenital or idiopathic, not directly caused by osteoporosis. While osteoporosis may exacerbate existing scoliosis through fractures, it’s not a primary deformity. Expecting scoliosis risks misdiagnosis, diverting focus from osteoporosis-related kyphosis and its management, like calcium supplementation or physical therapy.

Choice D reason: Lordosis, exaggerated lumbar curvature, is not typical in osteoporosis. Osteoporosis primarily affects thoracic vertebrae, causing kyphosis from compression fractures. Lordosis may occur in other conditions like muscular imbalances, but expecting it in osteoporosis misguides assessment, delaying interventions for fracture prevention and spinal stability in older adults.

Choice A reason: Interleukin 1 is a pro-inflammatory cytokine involved in gout’s acute inflammatory response, not directly targeted by allopurinol. Allopurinol reduces uric acid production, preventing crystal formation, not cytokine levels. This choice is incorrect, as it misaligns with the medication’s mechanism of action in chronic gout management.

Choice B reason: Allopurinol inhibits xanthine oxidase, reducing uric acid production, which is elevated in chronic tophaceous gout. Lowering uric acid levels prevents urate crystal formation in joints, reducing tophi and gout attacks. This is the correct explanation, as allopurinol directly targets hyperuricemia, the root cause of gout pathology.

Choice C reason: Potassium levels are unrelated to gout or allopurinol’s action. Allopurinol does not affect electrolyte balance but focuses on purine metabolism to lower uric acid. This choice is incorrect, as potassium is not involved in gout’s pathophysiology or the therapeutic effect of allopurinol.

Choice D reason: Chloride is an electrolyte not associated with gout or allopurinol’s mechanism. Allopurinol’s role is specific to uric acid reduction, not chloride homeostasis. This choice is irrelevant, as chloride levels do not contribute to gout or require modification in chronic tophaceous gout management.